These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 1576403)

  • 41. Hyperproduction of inhibitor-susceptible TEM beta-lactamase is responsible for resistance of Serratia marcescens to beta-lactam-beta-lactamase inhibitor combinations.
    Zhao WH; Hu ZQ; Chen G; Ito R; Shimamura T
    Chemotherapy; 2008; 54(1):31-7. PubMed ID: 18063864
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The in vitro antibacterial activity of ceftriaxone in comparison with nine other antibiotics.
    Emmerson AM; Lamport PA; Reeves DS; Bywater MJ; Holt HA; Wise R; Andrews J; Hall MJ
    Curr Med Res Opin; 1985; 9(7):480-93. PubMed ID: 3928265
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Characterization of a new plasmid-mediated extended-spectrum beta-lactamase from Serratia marcescens.
    Kunugita C; Higashitani F; Hyodo A; Unemi N; Inoue M
    J Antibiot (Tokyo); 1995 Dec; 48(12):1453-9. PubMed ID: 8557603
    [TBL] [Abstract][Full Text] [Related]  

  • 44. ACT-10, a novel plasmid-encoded class C β-lactamase in a Serratia marcescens isolate from China.
    Ma XJ; Yang HF; Liu YY; Mei Q; Ye Y; Li HR; Cheng J; Li JB
    Diagn Microbiol Infect Dis; 2014 Dec; 80(4):343-4. PubMed ID: 25312010
    [No Abstract]   [Full Text] [Related]  

  • 45. Evaluation of high-level carbapenem resistance in atypical Serratia marcescens by a comparison with its revertants.
    Marumo K; Nagaki T; Nakamura Y
    J Antimicrob Chemother; 1996 Jul; 38(1):47-58. PubMed ID: 8858456
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Antimicrobial activity of RU29246 (HR916 metabolite) compared with four other oral beta-lactams tested against more than 5000 clinical isolates.
    Murray PR; Allen SD; Erwin ME; Gerlach EH; Jones RN; Koontz FP; Pfaller MA; Washington JA
    Eur J Clin Microbiol Infect Dis; 1991 Sep; 10(9):776-81. PubMed ID: 1810737
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Antibacterial activity of temocillin.
    Malottke R; Potel J
    Drugs; 1985; 29 Suppl 5():67-73. PubMed ID: 3849426
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comparative in-vitro activity of cefdinir against multiresistant Haemophilus influenzae.
    Perea EJ; Garcia Iglesias MC
    J Antimicrob Chemother; 1994 Jul; 34(1):161-4. PubMed ID: 7961203
    [No Abstract]   [Full Text] [Related]  

  • 49. [In vitro comparative bactericidal effect of cefotaxime and cefixime in a kinetic model].
    Rolin O; Roche G; Bouanchaud DH
    Presse Med; 1989 Oct; 18(32):1569-71. PubMed ID: 2530534
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Tigecycline resistance in Serratia marcescens associated with up-regulation of the SdeXY-HasF efflux system also active against ciprofloxacin and cefpirome.
    Hornsey M; Ellington MJ; Doumith M; Hudson S; Livermore DM; Woodford N
    J Antimicrob Chemother; 2010 Mar; 65(3):479-82. PubMed ID: 20051474
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effect of beta-lactamase induction on susceptibility to cephalosporins in Enterobacter cloacae and Serratia marcescens.
    Okonogi K; Sugiura A; Kuno M; Higashide E; Kondo M; Imada A
    J Antimicrob Chemother; 1985 Jul; 16(1):31-42. PubMed ID: 3900023
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A comparison of the activity in vitro of different cephalosporins: cephalothin, cephradine, cephacetrile, cefaclor, cefuroxime and cefotaxime.
    Bianchi P; Frongillo RF
    Boll Ist Sieroter Milan; 1980 Jan; 58(6):488-95. PubMed ID: 6255966
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Minimal inhibitory and bactericidal concentrations of cefoperazone, cefotaxime, cefuroxime and cefalotin against 90 bacterial strains].
    Mascellino MT; Prignano G; Iegri F; Lorenzi A
    Boll Ist Sieroter Milan; 1982; 61(4):309-19. PubMed ID: 6100234
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Isolation of pigmented and nonpigmented mutants of Serratia marcescens with reduced cell surface hydrophobicity.
    Rosenberg M
    J Bacteriol; 1984 Oct; 160(1):480-2. PubMed ID: 6384200
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Screening extended-spectrum beta-lactamase production in Enterobacter cloacae and Serratia marcescens using antibiogram-based methods.
    Su PA; Wu LT; Cheng KC; Ko WC; Chuang YC; Yu WL
    J Microbiol Immunol Infect; 2010 Feb; 43(1):26-34. PubMed ID: 20434120
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Microbiological studies with the new penicillin BRL 17421 (temocillin)].
    Malottke R; Potel J
    Infection; 1983; 11(1):47-51. PubMed ID: 6302007
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Combined serum bactericidal and phagocytic activities of defibrinated human blood against Serratia marcescens. Use of phenylbutazone to selectively block phagocytic killing activity and of Group A (phage tail) bacteriocins to kill extraphagocytic bacteria.
    Traub WH
    Chemotherapy; 1982; 28(5):355-62. PubMed ID: 6754279
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Antibacterial activity of N-formimidoyl thienamycin in comparison with cefotaxime, lamoxactam, cefoperazone, piperacillin gentamicin.
    Braveny I; Machka K; Elsser R
    Infection; 1982 Jan; 10(1):45-9. PubMed ID: 6279523
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Analysis of susceptibility of bacteria isolated from clinical material to cefuroxime, ceftazidime and cefotaxime].
    Giedrys-Kalemba S; Bilska I
    Med Dosw Mikrobiol; 1993; 45(2):173-6. PubMed ID: 8309292
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Study on bacteriocin (marcescin) typing of Serratia marcescens. I. Fundamental studies on bacteriocin (marcescin) production and sensitivity (author's transl)].
    Nasu M
    Kansenshogaku Zasshi; 1977 Sep; 51(9):487-98. PubMed ID: 416153
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.